Analytik.news recently featured Inorganic Ventures in the article, "Trace-Level Testing, Validation Pressure, and the New Demands on Pharma Labs," examining how pharmaceutical labs are adapting to tighter impurity thresholds and faster development timelines.
The article explores how sample preparation, digestion, calibration alignment, traceability, and method validation all influence whether elemental impurity data can withstand regulatory












